-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS INC - PHASE 3 TRANSCEND TRIAL SHOWS SETMELANOTIDE REDUCES BMI IN HYPOTHALAMIC OBESITY

Reuters·07/12/2025 22:09:46

Please log in to view news